The bill establishes the Opioid Abatement Special Fund and outlines appropriations for fiscal year 2027 aimed at addressing substance use disorders in Vermont. Key allocations include $455,000 for outreach and case management staff, $1.6 million for certified recovery residences, $850,000 for syringe services, and $1.1 million for peer recovery coaches in correctional facilities. The bill emphasizes the intent of the General Assembly to fund these initiatives annually from the Special Fund, contingent on sufficient resources. Additionally, it mandates quarterly reporting on expenditures from the fund and requires the Department of Health to submit a syringe recovery plan by December 15, 2026.

The bill also includes provisions for the Substance Misuse Prevention Special Fund, allocating funds to various youth services and prevention programs. Notably, it amends existing laws to enhance the role of the Opioid Settlement Advisory Committee in consulting with stakeholders and ensuring sustainability in funding proposals. The act is set to take effect on July 1, 2026, and includes a suspension of new funding proposals for fiscal year 2028, focusing instead on reviewing the effectiveness of previously funded programs.

Statutes affected:
As Passed By the House -- Official: 18-4772
As Passed By the House -- Unofficial: 18-4772
As Passed by Both House and Senate -- Official: 18-4772, 18-4774, 18-4812
As Passed by Both House and Senate -- Unofficial: 18-4772, 18-4774, 18-4812
As Enacted: 18-4772, 18-4774, 18-4812